• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯氮卓和丙戊酸钠单次及重复给药对大鼠饮水量的影响及其对纳洛酮抗饮水作用的影响。

Effect of single and repeated treatment of chlordiazepoxide and sodium valproate on water intake in the rat and their influence on the antidipsogenic action of naloxone.

作者信息

Cannizzaro G, Brucato A F, Provenzano P M

出版信息

Arzneimittelforschung. 1986 Apr;36(4):718-21.

PMID:3087371
Abstract

The action of single and repeated treatment with chlordiazepoxide (CDP) (5-10 mg/kg i.p.) and sodium valproate (VPA) (100-200 mg/kg i.p.) on water intake of rats adapted to a daily 23-h water deprivation schedule was investigated. The influence exerted by single or repeated treatment of the two drugs on the antidipsogenic effect of naloxone (Nx) (1 mg/kg s.c.) was studied too. Our results show that with single treatment of CDP the dipsogenic effect is lower and not further modified by increasing dose and by the time-course of the session; with repeated treatment the dipsogenic effect is greater and further enhanced by increasing dose and by the time-course of the session. Single or repeated treatment with VPA does not significantly affect the water intake. Single treatment of CDP enhances the antidipsogenic effect of Nx, while CDP, after repeated treatment, reverses the antidipsogenic effect of Nx. With VPA-Nx association, the response is univocal (antidipsogenic effect) independent of the experimental conditions. The results are briefly discussed.

摘要

研究了单次及重复给予氯氮卓(CDP)(腹腔注射5 - 10毫克/千克)和丙戊酸钠(VPA)(腹腔注射100 - 200毫克/千克)对适应每日23小时禁水方案的大鼠饮水量的影响。还研究了这两种药物单次或重复给药对纳洛酮(Nx)(皮下注射1毫克/千克)抗饮水作用的影响。我们的结果表明,单次给予CDP时,饮水诱导作用较低,且增加剂量和给药时间过程不会进一步改变该作用;重复给药时,饮水诱导作用更大,且增加剂量和给药时间过程会进一步增强该作用。单次或重复给予VPA对饮水量无显著影响。单次给予CDP可增强Nx的抗饮水作用,而重复给药后,CDP会逆转Nx的抗饮水作用。对于VPA - Nx联合用药,无论实验条件如何,反应都是单一的(抗饮水作用)。对结果进行了简要讨论。

相似文献

1
Effect of single and repeated treatment of chlordiazepoxide and sodium valproate on water intake in the rat and their influence on the antidipsogenic action of naloxone.氯氮卓和丙戊酸钠单次及重复给药对大鼠饮水量的影响及其对纳洛酮抗饮水作用的影响。
Arzneimittelforschung. 1986 Apr;36(4):718-21.
2
Interaction between naloxone, chlordiazepoxide and valproic acid evaluated by emotional operant behaviour in the rat.通过大鼠情绪性操作行为评估纳洛酮、氯氮卓和丙戊酸之间的相互作用。
Arzneimittelforschung. 1987 Jan;37(1):6-9.
3
Antidipsogenic action of naloxone under different water deprivation conditions.纳洛酮在不同缺水条件下的抗渴作用。
Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(2-3):195-202. doi: 10.1016/0278-5846(83)90107-0.
4
[Effects of clonidine on diuresis and water intake in normal and Brattleboro rats. (author's transl)].可乐定对正常大鼠和遗传性尿崩症大鼠利尿及水摄入的影响。(作者译)
J Pharmacol. 1981 Jul-Sep;12(3):277-88.
5
Antidipsogenic effect of endotoxin in the rat.
Circ Shock. 1983;11(4):341-50.
6
Suppression of alcohol intake by chronic naloxone treatment in P rats: tolerance development and elevation of opiate receptor binding.慢性纳洛酮治疗对P大鼠酒精摄入量的抑制作用:耐受性发展及阿片受体结合的升高
Alcohol Clin Exp Res. 1999 Nov;23(11):1761-71.
7
Chlordiazepoxide and valproate enhancement of saline drinking by nondeprived rats: effects of bicuculline, picrotoxin and Ro15-1788.氯氮卓和丙戊酸盐对未禁食大鼠盐水饮用的增强作用:荷包牡丹碱、印防己毒素和Ro15 - 1788的影响
Pharmacol Biochem Behav. 1989 Jun;33(2):285-90. doi: 10.1016/0091-3057(89)90501-7.
8
Effects of chlordiazepoxide and sodium valproate in two tests of spatial behaviour.
Pharmacol Biochem Behav. 1986 Oct;25(4):747-51. doi: 10.1016/0091-3057(86)90381-3.
9
The effects of single doses of alkali metal cations on deprivation-induced fluid consumption by rats.
Res Commun Chem Pathol Pharmacol. 1981 Dec;34(3):493-502.
10
Chlordiazepoxide and the moderation of the initial response to reward reduction.氯氮卓与对奖励减少的初始反应的调节
Q J Exp Psychol B. 1990 Feb;42(1):87-105.